1Q13 Brilinta sales: $51M, +34% from 4Q12, but still a long way from being the centerpiece of AZN’s portfolio that CEO, Pascal Soriot asserts it will be.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.